相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Jinghui Zhang et al.
NATURE (2012)
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Roy Fleischmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Ronald F. van Vollenhoven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Janus Kinase 3-Activating Mutations Identified in Natural Killer/T-cell Lymphoma
Ghee Chong Koo et al.
CANCER DISCOVERY (2012)
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP
Wei Ju et al.
BLOOD (2011)
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
Arnaud Jaccard et al.
BLOOD (2011)
Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma
Siok-Bian Ng et al.
BLOOD (2011)
FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma
Natalina E. Elliott et al.
BLOOD (2011)
Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses
Kennosuke Karube et al.
BLOOD (2011)
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
Peter Friedl et al.
CELL (2011)
Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro
J. Iqbal et al.
LEUKEMIA (2011)
PRDM1 is a tumor suppressor gene in natural killer cell malignancies
Can Kuecuek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
Yenlin Huang et al.
BLOOD (2010)
Modeling and quantification of cancer cell invasion through collagen type I matrices
Olivier De Wever et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2010)
IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis
Georgia Malamut et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
Wing-yan Au et al.
BLOOD (2009)
Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models
Melanie G. Cornejo et al.
BLOOD (2009)
Extranodal NK/T-cell lymphoma, nasal type: New staging system and treatment strategies
Tae Min Kim et al.
CANCER SCIENCE (2009)
JAK3: A two-faced player in hematological disorders
Melanie G. Cornejo et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma
P. Coppo et al.
LEUKEMIA (2009)
Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group
T. M. Kim et al.
ANNALS OF ONCOLOGY (2008)
Classification of lymphoid neoplasms: the microscope as a tool for disease discovery
Elaine S. Jaffe et al.
BLOOD (2008)
Activating mutations in human acute megakaryoblastic leukemia
Sebastien Malinge et al.
BLOOD (2008)
Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2
Joseph M. Gozgit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
JAK kinases overexpression promotes in vitro cell transformation
L. Knoops et al.
ONCOGENE (2008)
Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T cell lymphoma:: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials
Celine Bossard et al.
BLOOD (2007)
Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid modes of tumour cell invasion: a link to integrin function
N. O. Carragher et al.
ONCOGENE (2006)
Activating alleles of JAK3 in acute megakaryoblastic leukemia
Denise K. Walters et al.
CANCER CELL (2006)
Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK/T-cell lymphoma
YK Jeon et al.
LABORATORY INVESTIGATION (2005)
Identification of NPM-ALK interacting proteins by tandem mass spectrometry
DK Crockett et al.
ONCOGENE (2004)
IL-9 and its receptor: From signal transduction to tumorigenesis
L Knoops et al.
GROWTH FACTORS (2004)
P53, N- and K-ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan
M Takahara et al.
HUMAN PATHOLOGY (2004)
Classification of cytotoxic T-Cell and natural killer cell lymphomas
ES Jaffe et al.
SEMINARS IN HEMATOLOGY (2003)
Frequent mutations of Fas gene in nasal NK/T cell lymphoma
T Takakuwa et al.
ONCOGENE (2002)
p53 mutations in nasal natural killer/T-cell lymphoma from Mexico - Association with large cell morphology and advanced disease
L Quintanilla-Martinez et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation
K Nagafuji et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2001)
Malignant hematopoietic cell lines:: in vitro models for the study of natural killer cell leukemia-lymphoma
HG Drexler et al.
LEUKEMIA (2000)
分享论文
